Abstract:Aims Malignancy and surgery are risk factors for venous thromboembolism (VTE). We undertook a systematic review of the literature concerning the prophylactic management of VTE in orthopaedic oncology patients. Methods MEDLINE (PubMed), EMBASE (Ovid), Cochrane, and CINAHL databases were searched focusing on VTE, deep vein thrombosis (DVT), pulmonary embolism (PE), bleeding, or wound complication rates. Results In all, 17 studies published from 1998 to 2018 met the inclusion criteria for the systematic review. T… Show more
“…The study by Yamaguchi et al, identified age > 70 years as a risk factor for VTE events in 94 patients undergoing musculoskeletal tumor resection 98 . In contrast, other studies were not able to detect an association between age and VTE occurrence 96,97,99,100 .…”
Section: - Is There a Correlation Between Age And The Risk Of Vte In ...mentioning
confidence: 66%
“…The influence of age on VTE risk in patients with fractures of the lower extremity and oncologic orthopaedic surgeries were not consistent 92-101 . In patients undergoing surgical treatment of fractures below the hip, age ≥ 60 years was identified as a risk factor for VTE (RR 1.85 [95% CI 1.34 - 2.55]) in 191,294 patients 92 .…”
Section: - Is There a Correlation Between Age And The Risk Of Vte In ...mentioning
confidence: 94%
“…Rationale: Cancer patients have a hypercoagulable state due to the presence of all components of Virchow's triad. There is evidence of platelet activation along with elevated levels of inflammatory cytokines (vascular endothelial growth factor, tissue factor), tumor mass effect compressing adjacent veins and damage to the endothelium 295 .…”
Section: % (Strong Consensus)mentioning
confidence: 99%
“…The authors recommended apixaban, rivaroxaban, or LMWH in high-risk cancer patients and advised for the start of pharmacotherapy prior to surgery and to continue 7 - 10 days after surgery. A systematic review by Lex et al, was performed regarding VTE prophylaxis in orthopaedic oncology patients 1443 . The authors concluded that there is limited evidence to guide clinicians in VTE prophylaxis in this population.…”
Section: - If a Patient Is In An "Increased Risk" Group For The Devel...mentioning
A common genetic variation in the 39-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
“…The study by Yamaguchi et al, identified age > 70 years as a risk factor for VTE events in 94 patients undergoing musculoskeletal tumor resection 98 . In contrast, other studies were not able to detect an association between age and VTE occurrence 96,97,99,100 .…”
Section: - Is There a Correlation Between Age And The Risk Of Vte In ...mentioning
confidence: 66%
“…The influence of age on VTE risk in patients with fractures of the lower extremity and oncologic orthopaedic surgeries were not consistent 92-101 . In patients undergoing surgical treatment of fractures below the hip, age ≥ 60 years was identified as a risk factor for VTE (RR 1.85 [95% CI 1.34 - 2.55]) in 191,294 patients 92 .…”
Section: - Is There a Correlation Between Age And The Risk Of Vte In ...mentioning
confidence: 94%
“…Rationale: Cancer patients have a hypercoagulable state due to the presence of all components of Virchow's triad. There is evidence of platelet activation along with elevated levels of inflammatory cytokines (vascular endothelial growth factor, tissue factor), tumor mass effect compressing adjacent veins and damage to the endothelium 295 .…”
Section: % (Strong Consensus)mentioning
confidence: 99%
“…The authors recommended apixaban, rivaroxaban, or LMWH in high-risk cancer patients and advised for the start of pharmacotherapy prior to surgery and to continue 7 - 10 days after surgery. A systematic review by Lex et al, was performed regarding VTE prophylaxis in orthopaedic oncology patients 1443 . The authors concluded that there is limited evidence to guide clinicians in VTE prophylaxis in this population.…”
Section: - If a Patient Is In An "Increased Risk" Group For The Devel...mentioning
A common genetic variation in the 39-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
“…Rationale: Major orthopaedic surgeries and oncological patients have increased risk for VTE, with the mean incidence of all VTE events in orthopaedic oncology patients being 10.7% (1.1% to 27.7%). Risk factors for increased events include endoprosthetic replacements, hip and pelvic resections, surgical procedures taking longer than 3 hours, and chemotherapy 14 , all of which are common with sarcoma surgeries. Higher preoperative white blood cell count (odds ratio [OR] 1.15, 95% confidence interval [CI] 1.01-1.29) and post-operative wound complications (OR 5.01, 95% CI 1.93-13.55) were found to be independent risk factors for VTE 15 .…”
Section: - For Primary Bone Tumours/sarcoma Patientsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.